Article
America's Top War Unicorn To Begin Combat Drone Production As Next-Gen Startups Challenge Big Defense Primes
America's Top War Unicorn To Begin Combat Drone Production As Next-Gen Startups Challenge Big Defense Primes
Weaponized AI, interceptor drones, automated kill chains, ground robots armed with machine guns, humanoid robots, and FPVs equipped with shaped charges all offer a scary preview of what warfare in the 2030s was expected to look like.
Instead, four years of war in Ukraine, followed by the U.S.-Iran conflict, have sharply accelerated that timeline, pulling the future of warfare into today. These are truly frightening times, as defenses against this technology are still lacking across...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Apr 14, 2026 / Tyler Durden
Australia's Qantas To Cut Domestic Flights Amid Fuel Price Surge
Australia's Qantas To Cut Domestic Flights Amid Fuel Price Surge
Authored by Monica O'Shea via The Epoch Times (emphasis ours),
Australia’s flag carrier Qantas will cut domestic flights and redeploy capacity from the United States towards Europe as fuel prices double.
Qantas Airways ground staff are seen on the tarmac near planes at the domestic terminal of Sydney International Airport in Sydney, Australia on Jan. 14, 2026. David Gray/ AFP via Getty Images
Qantas revealed fuel costs remained turbulent amid the Iran War in an update on its 2026 financial outlook, which noted...
Read more
May 6, 2026 / Tyler Durden
Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance
Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance
Novo Nordisk shares jumped as much as 9% in Copenhagen, suggesting the stock may finally be bottoming out after a vicious multi-year bear market. The move followed the Danish drugmaker's decision to raise its 2026 guidance ranges for adjusted sales and adjusted operating profit, citing solid momentum in Wegovy sales.
Novo now expects full-year sales and profit declines of around 12%, down from a previous forecast of around 13%. The upgraded outlook was "driven by increased expectations for GLP-1 product sales,"...
Read more
Apr 6, 2026 / Tyler Durden
Top University Dubbed 'MIT Of Iran' Bombed Along With Several Airports




